Category Archives: Cancer

Malignancy, tumor and abnormal cell growth

New Prostate Cancer Drug Approved by FDA

Good news for patients with metastatic prostate cancer.  The FDA (US Food and Drug Administration) has approved Johnson & Johnson’s Zytiga (abiraterone) in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy.  Abiraterone … Continue reading

Posted in Cancer, Prostate cancer | Tagged , , , , , , , , , | 1 Comment

FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

The US Food and Drug Administration (FDA) has approved everolimus (Afinitor) to treat patients with advanced pancreatic neuroendocrine tumors (pNETs).  pNETs is a rare, slow-growing form of pancreatic cancer.  In theUnited States, there are fewer than 1000 new pNET cases … Continue reading

Posted in Cancer, Pancreatic Cancer | Tagged , , , , , , , , , , , , , | Comments Off on FDA Approved Afinitor for a Type of Advanced Pancreatic Cancer

New Monoclonal Antibodies Increased Survival in Lung Cancer Patients

A new study showed that non-small-cell lung cancer (NSCLC) patients who have high level of Met proteins in their tumor can have their survival increase three-fold by receiving experimental antibody MetMAb in combination with erlotinib (Tarceva).  In the trial, 137 previously-treated … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , , , , | Comments Off on New Monoclonal Antibodies Increased Survival in Lung Cancer Patients

Another New Cancer Drug Crizotinib Shows Improvement in Survival

It looks like a number of new drugs might become available to lung cancer patients in the near future.  Results of an early-stage study suggested that nearly two-thirds of patients with late stage non-small-cell lung cancer who received the experimental … Continue reading

Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer | Tagged , , , , , | Comments Off on Another New Cancer Drug Crizotinib Shows Improvement in Survival

What should you do if you have Prostate Cancer?

You should check whether you are overweight or obese*.  If you have prostate cancer and are overweight, you should try to lower your weight immediately.   A new study presented at the American Urological Association inWashington,DCfound that overweight and obese prostate … Continue reading

Posted in Cancer, Cardiovascular disease, Prostate cancer | Tagged , , , , , , , | Comments Off on What should you do if you have Prostate Cancer?

Latest Medical Consensus on Preventing Breast Cancer

Breast cancer is the most common cancer in women worldwide, with the annual incidence estimated to be 1.4 million cases in 2008.  Rates are highest in North American, Western Europe andAustralia, but the rates are also increasing in developing countries.  … Continue reading

Posted in Breast cancer, Cancer | Tagged , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Latest Medical Consensus on Preventing Breast Cancer

Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Transitional cell or urothelial carcinoma is the most common type of bladder cancer, accounting for more than 90% all bladder cancers.  This type of cancer is sensitive to treatment with chemotherapeutic agents.   This type of cancer is usually treated with … Continue reading

Posted in Bladder Cancer, Cancer | Tagged , , , , , , , , , , | Comments Off on Which is Best Chemotherapy Option for Advanced Bladder Cancer?

Strawberries May Prevent Esophageal Cancer

Esophageal cancer is common inChina, with about 50% of the world wide cases of esophageal cancer reported inChinaalone.  The important causative agents of esophageal squamous cell carcinoma are nitrosamine carcinogens, which are present in tobacco smoke.  Now, a pilot study … Continue reading

Posted in Alternative Medicine, Cancer, Esophageal Cancer | Tagged , , , , , | Comments Off on Strawberries May Prevent Esophageal Cancer

New Personalized Medicine Increases Survival in Melanoma Patients

Metastatic melanoma is the deadliest and most aggressive from of skin cancer.  A person with metastatic melanoma typically has a short life expectancy that is measured in months.   The mainstay treatments for metastatic melanoma are dacarbazine (DTIC), interleukin-2 (IL-2) and … Continue reading

Posted in Cancer, Melanoma | Tagged , , , , , , , , , , , , , , | Comments Off on New Personalized Medicine Increases Survival in Melanoma Patients